Back to Search
Start Over
Response by Chatur et al to Letter Regarding Article, "Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial".
- Source :
-
Circulation [Circulation] 2024 Aug 06; Vol. 150 (6), pp. e107-e108. Date of Electronic Publication: 2024 Aug 05. - Publication Year :
- 2024
-
Abstract
- Competing Interests: S.C. is supported by the Canadian Arthur J.E. Child’s Cardiology Fellowship. M.V. has received research grant support, served on advisory boards, or had speaker engagements with American Regent, Amgen, AstraZeneca, Bayer AG, Baxter Healthcare, Boehringer Ingelheim, Chiesi, Cytokinetics, Lexicon Pharmaceuticals, Merck, Novartis, Novo Nordisk, Pharmacosmos, Relypsa, Roche Diagnostics, Sanofi, and Tricog Health; and has participated on clinical trial committees for studies sponsored by AstraZeneca, Galmed, Novartis, Bayer Aktiengesellschaft, Occlutech, and Impulse Dynamics. B.L.C. has consulted for Amgen, AO Biome, Biogen, Boehringer Ingelheim, Corvia, Gilead, Myokardia, Cardurion, and Novartis. S.D.S. has received research grants from Actelion, Alnylam, Amgen, AstraZeneca, Bellerophon, Bayer, BMS, Celladon, Cytokinetics, Eidos, Gilead, GSK, Ionis, Lilly, Mesoblast, MyoKardia, National Institutes of Heatlh/National Heart Lung and Blood Institute, Neurotronik, Novartis, NovoNordisk, Respicardia, Sanofi Pasteur, Theracos, and US2.AI; and has consulted for Abbott, Action, Akros, Alnylam, Amgen, Arena, AstraZeneca, Bayer, Boeringer-Ingelheim, BMS, Cardior, Cardurion, Corvia, Cytokinetics, Daiichi-Sankyo, GSK, Lilly, Merck, Myokardia, Novartis, Roche, Theracos, Quantum Genomics, Cardurion, Janssen, Cardiac Dimensions, Tenaya, Sanofi-Pasteur, Dinaqor, Tremeau, CellProThera, Moderna, American Regent, Sarepta, Lexicon, Anacardio, Akros, and Puretech Health.
Details
- Language :
- English
- ISSN :
- 1524-4539
- Volume :
- 150
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Circulation
- Publication Type :
- Editorial & Opinion
- Accession number :
- 39102479
- Full Text :
- https://doi.org/10.1161/CIRCULATIONAHA.124.069376